CN Stock MarketDetailed Quotes

605077 Zhejiang Huakang Pharmaceutical

Watchlist
  • 16.08
  • -0.10-0.62%
Trading Jun 5 10:02 CST
4.90BMarket Cap13.57P/E (TTM)

Zhejiang Huakang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-2.39%634.82M
26.48%2.78B
28.56%2.04B
44.09%1.37B
60.42%650.33M
38.02%2.2B
33.71%1.59B
29.92%949.97M
23.34%405.4M
20.79%1.59B
Operating revenue
-2.39%634.82M
26.48%2.78B
28.56%2.04B
44.09%1.37B
60.42%650.33M
38.02%2.2B
33.71%1.59B
29.92%949.97M
23.34%405.4M
20.79%1.59B
Other operating revenue
----
162.58%51.27M
----
46.31%10.23M
----
201.62%19.52M
----
110.72%6.99M
----
-2.85%6.47M
Total operating cost
0.90%561.14M
27.03%2.39B
28.02%1.74B
37.78%1.16B
48.43%556.15M
34.61%1.89B
33.63%1.36B
36.49%845.33M
38.06%374.69M
38.38%1.4B
Operating cost
-3.40%482.35M
24.45%2.11B
25.63%1.55B
39.01%1.05B
52.17%499.34M
38.18%1.7B
37.09%1.23B
37.46%751.89M
36.53%328.14M
42.96%1.23B
Operating tax surcharges
109.27%6.23M
121.12%23.5M
115.13%15.57M
97.65%9.15M
44.27%2.98M
31.03%10.63M
16.06%7.24M
27.33%4.63M
10.61%2.06M
-11.63%8.11M
Operating expense
36.65%10.58M
25.41%44.9M
21.02%27.33M
32.69%18.84M
22.56%7.74M
28.97%35.8M
0.15%22.58M
10.54%14.2M
18.24%6.31M
50.52%27.76M
Administration expense
33.37%26.14M
16.88%82.78M
7.42%55.42M
18.36%37.3M
36.20%19.6M
33.77%70.82M
42.60%51.59M
28.01%31.51M
22.09%14.39M
9.98%52.95M
Financial expense
-37.49%4.66M
135.41%9.6M
105.99%1.4M
52.96%-5.16M
344.07%7.46M
-4,903.44%-27.11M
-383.13%-23.32M
-390.66%-10.97M
140.58%1.68M
-95.68%564.36K
-Interest expense (Financial expense)
47.05%9.85M
160.94%37.15M
174.65%27.08M
222.37%16.76M
694.75%6.7M
265.39%14.24M
261.29%9.86M
151.61%5.2M
-40.47%842.94K
-53.85%3.9M
-Interest Income (Financial expense)
1.03%-4.24M
-36.00%-21.21M
-57.99%-17.08M
-74.12%-10.12M
-459.65%-4.29M
-146.58%-15.59M
-33.34%-10.81M
3.20%-5.81M
85.72%-765.84K
-179.84%-6.32M
Research and development
63.87%31.18M
24.63%124.28M
33.89%95.34M
9.69%59.29M
-13.88%19.03M
18.38%99.71M
18.90%71.21M
61.35%54.06M
36.49%22.09M
29.52%84.23M
Credit Impairment Loss
-265.95%-2.04M
37.76%-4.68M
83.16%-1.84M
68.44%-1.94M
30.63%-556.55K
-79.35%-7.51M
-101.94%-10.93M
-30.81%-6.14M
72.87%-802.33K
-357.39%-4.19M
Asset Impairment Loss
-1.48%-336.36K
-10.91%-1.1M
--723.18K
--473.14K
---331.46K
12.45%-990.95K
----
----
----
---1.13M
Other net revenue
52.50%11.89M
14.01%39.23M
-69.98%14.83M
-94.40%2.46M
-67.67%7.79M
-45.49%34.41M
31.04%49.41M
144.20%43.87M
18,859.60%24.11M
30.15%63.13M
Fair value change income
-106.64%-151.56K
201.60%9.8M
514.67%2.03M
-2,381.95%-3.72M
51,418.32%2.28M
-19,398.96%-9.65M
-70.45%329.75K
92.72%-150.05K
99.70%-4.45K
--50K
Invest income
138.50%10.02M
-78.57%7.06M
-98.16%816.74K
-95.57%1.66M
-79.91%4.2M
-35.90%32.94M
49.12%44.47M
92.80%37.33M
625.76%20.9M
133.91%51.38M
-Including: Investment income associates
-37.99%3.72M
-69.17%11.18M
-59.16%10.2M
-62.20%9.44M
-52.12%5.99M
89.83%36.26M
127.53%24.98M
275.52%24.98M
383.43%12.51M
-14.87%19.1M
Asset deal income
----
-118.27%-6.02K
-75.74%19.36K
----
----
-37.75%32.93K
72.50%79.82K
564.52%85.62K
----
122.36%52.9K
Other revenue
99.70%4.39M
43.66%28.15M
-15.30%13.09M
-52.98%5.99M
-45.14%2.2M
15.50%19.59M
27.39%15.45M
138.42%12.74M
182.41%4.01M
-32.54%16.96M
Operating profit
-16.10%85.56M
22.29%427.09M
13.59%313.72M
39.10%206.57M
86.04%101.98M
36.08%349.23M
33.64%276.19M
14.41%148.51M
-4.10%54.82M
-27.93%256.64M
Add:Non operating Income
-98.59%6.07K
-4.35%1.25M
-32.77%731.36K
23.99%757.74K
-16.17%428.82K
247.25%1.31M
256.08%1.09M
268.15%611.14K
77,221.82%511.51K
-69.27%376.59K
Less:Non operating expense
-96.07%64.41K
-23.47%5.94M
72.54%4.75M
118.70%5.17M
9.21%1.64M
162.89%7.76M
45.75%2.75M
465.02%2.36M
839.91%1.5M
-66.56%2.95M
Total profit
-15.16%85.5M
23.23%422.4M
12.82%309.71M
37.76%202.16M
87.21%100.77M
34.92%342.78M
33.86%274.52M
13.28%146.75M
-5.57%53.83M
-27.10%254.07M
Less:Income tax cost
-48.47%5.56M
112.81%50.02M
73.42%34.52M
251.42%16.93M
204.95%10.79M
35.39%23.5M
-6.95%19.9M
-65.19%4.82M
-36.50%3.54M
-58.02%17.36M
Net profit
-11.16%79.94M
16.63%372.38M
8.08%275.19M
30.50%185.23M
78.92%89.98M
34.88%319.28M
38.61%254.62M
22.67%141.94M
-2.21%50.29M
-22.94%236.71M
Net profit from continuing operation
-11.16%79.94M
16.63%372.38M
8.08%275.19M
30.50%185.23M
78.92%89.98M
34.88%319.28M
38.61%254.62M
22.67%141.94M
-2.21%50.29M
-22.94%236.71M
Less:Minority Profit
-10.53%-60.36K
--931.99K
--436.83K
--55.32K
---54.61K
----
----
----
----
----
Net profit of parent company owners
-11.15%80M
16.34%371.45M
7.91%274.75M
30.46%185.18M
79.03%90.03M
34.88%319.28M
38.61%254.62M
22.67%141.94M
-2.21%50.29M
-22.94%236.71M
Earning per share
Basic earning per share
-10.26%0.35
16.43%1.63
8.11%1.2
30.65%0.81
77.27%0.39
30.84%1.4
32.14%1.11
14.81%0.62
-58.49%0.22
-69.52%1.07
Diluted earning per share
-28.21%0.28
16.43%1.63
8.11%1.2
30.65%0.81
77.27%0.39
30.84%1.4
32.14%1.11
14.81%0.62
-58.49%0.22
-69.52%1.07
Other composite income
-575.77%-3.16K
37.10%6.08K
195.35%2.02K
346.67%5.28K
167.20%664.04
239.17%4.44K
-320.21%-2.11K
-5,928.85%-2.14K
45.56%-988.18
-370.55%-3.19K
Other composite income of parent company owners
-575.77%-3.16K
37.10%6.08K
195.35%2.02K
346.67%5.28K
167.20%664.04
239.17%4.44K
---2.11K
-5,928.85%-2.14K
45.56%-988.18
-370.55%-3.19K
Total composite income
-11.16%79.94M
16.63%372.39M
8.08%275.19M
30.51%185.24M
78.93%89.98M
34.89%319.28M
38.61%254.62M
22.67%141.93M
-2.21%50.29M
-22.94%236.71M
Total composite income of parent company owners
-11.15%80M
16.34%371.46M
7.91%274.75M
30.47%185.18M
79.04%90.03M
34.89%319.28M
38.61%254.62M
22.67%141.93M
-2.21%50.29M
-22.94%236.71M
Total composite income of minority owners
-10.53%-60.36K
--931.99K
--436.83K
--55.32K
---54.61K
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -2.39%634.82M26.48%2.78B28.56%2.04B44.09%1.37B60.42%650.33M38.02%2.2B33.71%1.59B29.92%949.97M23.34%405.4M20.79%1.59B
Operating revenue -2.39%634.82M26.48%2.78B28.56%2.04B44.09%1.37B60.42%650.33M38.02%2.2B33.71%1.59B29.92%949.97M23.34%405.4M20.79%1.59B
Other operating revenue ----162.58%51.27M----46.31%10.23M----201.62%19.52M----110.72%6.99M-----2.85%6.47M
Total operating cost 0.90%561.14M27.03%2.39B28.02%1.74B37.78%1.16B48.43%556.15M34.61%1.89B33.63%1.36B36.49%845.33M38.06%374.69M38.38%1.4B
Operating cost -3.40%482.35M24.45%2.11B25.63%1.55B39.01%1.05B52.17%499.34M38.18%1.7B37.09%1.23B37.46%751.89M36.53%328.14M42.96%1.23B
Operating tax surcharges 109.27%6.23M121.12%23.5M115.13%15.57M97.65%9.15M44.27%2.98M31.03%10.63M16.06%7.24M27.33%4.63M10.61%2.06M-11.63%8.11M
Operating expense 36.65%10.58M25.41%44.9M21.02%27.33M32.69%18.84M22.56%7.74M28.97%35.8M0.15%22.58M10.54%14.2M18.24%6.31M50.52%27.76M
Administration expense 33.37%26.14M16.88%82.78M7.42%55.42M18.36%37.3M36.20%19.6M33.77%70.82M42.60%51.59M28.01%31.51M22.09%14.39M9.98%52.95M
Financial expense -37.49%4.66M135.41%9.6M105.99%1.4M52.96%-5.16M344.07%7.46M-4,903.44%-27.11M-383.13%-23.32M-390.66%-10.97M140.58%1.68M-95.68%564.36K
-Interest expense (Financial expense) 47.05%9.85M160.94%37.15M174.65%27.08M222.37%16.76M694.75%6.7M265.39%14.24M261.29%9.86M151.61%5.2M-40.47%842.94K-53.85%3.9M
-Interest Income (Financial expense) 1.03%-4.24M-36.00%-21.21M-57.99%-17.08M-74.12%-10.12M-459.65%-4.29M-146.58%-15.59M-33.34%-10.81M3.20%-5.81M85.72%-765.84K-179.84%-6.32M
Research and development 63.87%31.18M24.63%124.28M33.89%95.34M9.69%59.29M-13.88%19.03M18.38%99.71M18.90%71.21M61.35%54.06M36.49%22.09M29.52%84.23M
Credit Impairment Loss -265.95%-2.04M37.76%-4.68M83.16%-1.84M68.44%-1.94M30.63%-556.55K-79.35%-7.51M-101.94%-10.93M-30.81%-6.14M72.87%-802.33K-357.39%-4.19M
Asset Impairment Loss -1.48%-336.36K-10.91%-1.1M--723.18K--473.14K---331.46K12.45%-990.95K---------------1.13M
Other net revenue 52.50%11.89M14.01%39.23M-69.98%14.83M-94.40%2.46M-67.67%7.79M-45.49%34.41M31.04%49.41M144.20%43.87M18,859.60%24.11M30.15%63.13M
Fair value change income -106.64%-151.56K201.60%9.8M514.67%2.03M-2,381.95%-3.72M51,418.32%2.28M-19,398.96%-9.65M-70.45%329.75K92.72%-150.05K99.70%-4.45K--50K
Invest income 138.50%10.02M-78.57%7.06M-98.16%816.74K-95.57%1.66M-79.91%4.2M-35.90%32.94M49.12%44.47M92.80%37.33M625.76%20.9M133.91%51.38M
-Including: Investment income associates -37.99%3.72M-69.17%11.18M-59.16%10.2M-62.20%9.44M-52.12%5.99M89.83%36.26M127.53%24.98M275.52%24.98M383.43%12.51M-14.87%19.1M
Asset deal income -----118.27%-6.02K-75.74%19.36K---------37.75%32.93K72.50%79.82K564.52%85.62K----122.36%52.9K
Other revenue 99.70%4.39M43.66%28.15M-15.30%13.09M-52.98%5.99M-45.14%2.2M15.50%19.59M27.39%15.45M138.42%12.74M182.41%4.01M-32.54%16.96M
Operating profit -16.10%85.56M22.29%427.09M13.59%313.72M39.10%206.57M86.04%101.98M36.08%349.23M33.64%276.19M14.41%148.51M-4.10%54.82M-27.93%256.64M
Add:Non operating Income -98.59%6.07K-4.35%1.25M-32.77%731.36K23.99%757.74K-16.17%428.82K247.25%1.31M256.08%1.09M268.15%611.14K77,221.82%511.51K-69.27%376.59K
Less:Non operating expense -96.07%64.41K-23.47%5.94M72.54%4.75M118.70%5.17M9.21%1.64M162.89%7.76M45.75%2.75M465.02%2.36M839.91%1.5M-66.56%2.95M
Total profit -15.16%85.5M23.23%422.4M12.82%309.71M37.76%202.16M87.21%100.77M34.92%342.78M33.86%274.52M13.28%146.75M-5.57%53.83M-27.10%254.07M
Less:Income tax cost -48.47%5.56M112.81%50.02M73.42%34.52M251.42%16.93M204.95%10.79M35.39%23.5M-6.95%19.9M-65.19%4.82M-36.50%3.54M-58.02%17.36M
Net profit -11.16%79.94M16.63%372.38M8.08%275.19M30.50%185.23M78.92%89.98M34.88%319.28M38.61%254.62M22.67%141.94M-2.21%50.29M-22.94%236.71M
Net profit from continuing operation -11.16%79.94M16.63%372.38M8.08%275.19M30.50%185.23M78.92%89.98M34.88%319.28M38.61%254.62M22.67%141.94M-2.21%50.29M-22.94%236.71M
Less:Minority Profit -10.53%-60.36K--931.99K--436.83K--55.32K---54.61K--------------------
Net profit of parent company owners -11.15%80M16.34%371.45M7.91%274.75M30.46%185.18M79.03%90.03M34.88%319.28M38.61%254.62M22.67%141.94M-2.21%50.29M-22.94%236.71M
Earning per share
Basic earning per share -10.26%0.3516.43%1.638.11%1.230.65%0.8177.27%0.3930.84%1.432.14%1.1114.81%0.62-58.49%0.22-69.52%1.07
Diluted earning per share -28.21%0.2816.43%1.638.11%1.230.65%0.8177.27%0.3930.84%1.432.14%1.1114.81%0.62-58.49%0.22-69.52%1.07
Other composite income -575.77%-3.16K37.10%6.08K195.35%2.02K346.67%5.28K167.20%664.04239.17%4.44K-320.21%-2.11K-5,928.85%-2.14K45.56%-988.18-370.55%-3.19K
Other composite income of parent company owners -575.77%-3.16K37.10%6.08K195.35%2.02K346.67%5.28K167.20%664.04239.17%4.44K---2.11K-5,928.85%-2.14K45.56%-988.18-370.55%-3.19K
Total composite income -11.16%79.94M16.63%372.39M8.08%275.19M30.51%185.24M78.93%89.98M34.89%319.28M38.61%254.62M22.67%141.93M-2.21%50.29M-22.94%236.71M
Total composite income of parent company owners -11.15%80M16.34%371.46M7.91%274.75M30.47%185.18M79.04%90.03M34.89%319.28M38.61%254.62M22.67%141.93M-2.21%50.29M-22.94%236.71M
Total composite income of minority owners -10.53%-60.36K--931.99K--436.83K--55.32K---54.61K--------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg